The global interventional cardiology devices market was valued at USD 13.8 billion in 2021 and it is anticipated to grow further to USD 40.4 billion by 2031, at a CAGR of 11.3% during the forecast period.
Catheters are used in interventional cardiology to treat heart conditions. The procedure involves introducing a device, such as a balloon, stent, catheter, or another device, into the femoral artery or any other significant peripheral artery or vein, followed by the cannulation of the heart with the use of an X-ray. Additionally, a range of interventional cardiology tools is used to treat peripheral vascular issues that have an impact on the circulatory system and can result in the buildup of plaque in the arteries of the limbs. Some of the commercially available interventional cardiology devices include catheters, balloons, stents, and filters.
Get Access to A Free Sample Copy of Our Latest Report – https://www.globalinsightservices.com/request-sample/GIS10309
Market Trends and Drivers
The most prevalent form of heart disease in the US, coronary artery disease (CAD), claimed 365,914 lives in 2017, according to the Centers for Disease Control and Prevention (CDC). Additionally, according to the CDC’s estimations, 18.2 million Americans over the age of 20 currently have CAD. The British Heart Foundation estimates that 2.3 million persons in the UK had CAD as of June 2020. In the UK, heart and circulatory illnesses cause 170,000 deaths annually. The need for interventional cardiology devices is anticipated to rise in the upcoming years due to the enormous patient population and the high mortality rate.
The need for interventional cardiology equipment is also fueled by risk factors including diabetes and hypertension. Diabetes increases the likelihood of developing additional disorders that increase the risk of coronary heart disease. High blood sugar levels over time might harm the heart’s blood vessels. The International Diabetes Federation (IDF) projects that there will be 700 million individuals with diabetes worldwide by 2045, up from 463 million in 2019. Every year, 1.5 million people in the US alone are given a diabetes diagnosis [Source: American Diabetes Association (ADA)]. The rise in the number of elderly people can be partly blamed for the rise in diabetes prevalence.
Get Customized Report as Per Your Requirement – https://www.globalinsightservices.com/request-customization/GIS10309
Global Interventional Cardiology Devices Market Segmentation
By Type
- Angioplasty Balloons
- Angioplasty Stents
- Structural Heart Devices
- Catheters
- Plaque Modification Devices
- Hemodynamic Flow Alteration Devices
- Others
By End User
- Hospitals
- Ambulatory Surgical Centers
- Others
Major Players in the Global Interventional Cardiology Devices Market
The key players studied in the report are Medtronic (Ireland), Boston Scientific Corporation (US), Abbott (US), Edward Lifesciences Corporation (US), Cardinal Health (US), iVascular (Spain), B. Braun Melsungen (Germany), Terumo Corporation (Japan), Biosensors International Group (Singapore), and BIOTRONIK SE & Co. KG (Germany) among others.
COVID-19 Impact
The COVID-19 outbreak has had an effect on the market for interventional cardiology equipment as well as other areas of the medical device business globally. Despite the availability of emergency and outpatient department (OPD) services in cardiology departments, the number of patient visits to hospitals has decreased dramatically over the last six months. Patient visits have dramatically decreased as a result of widespread lockdowns and social isolation policies. The sales of interventional cardiology goods have been further decreased as a result. Many of the industry’s top companies, including Boston Scientific, Medtronic, and Abbott, have reported declining revenues for the second and third quarters of 2020.
With Global Insight Services, you receive:
- 10-year forecast to help you make strategic decisions
- In-depth segmentation which can be customized as per your requirements
- Free consultation with lead analyst of the report
- Excel data pack included with all report purchases
- Robust and transparent research methodology
Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: [email protected]
Phone: +1–833–761–1700
Website: https://www.globalinsightservices.com/